Investments News
Chugai, Gero ink $250m deal to target ageing
FierceBiotech - 07-Jul-2025
Gero’s AI will uncover ageing targets; Chugai will develop antibody drugs to treat related diseases
Read more...China’s brain chips break new ground
Nature - 04-Jul-2025
BCIs in China help paralysed users control devices, play games, and speak Mandarin in real time
Read more...Calico taps Mabwell’s anti-ageing antibody in $596m licensing deal
FierceBiotech - 26-Jun-2025
Alphabet's Calico licenses IL-11 drug to target age-related diseases beyond China
Read more...DNA reborn: engineering life from scratch
BBC - 26-Jun-2025
UK project aims to build human DNA from scratch, raising hopes for cures—and ethical concerns
Read more...Outsee raises 1.8m for AI genomics in drug discovery
Longevity Technology - 25-Jun-2025
Nomaly uses AI to decode disease from genomes, enabling precision medicine with small datasets
Read more...Robot surgeons for eyes: ForSight aims to revolutionize cataract surgery
Forbes - 24-Jun-2025
ForSight’s $125M boost powers eye-surgery robot tested in 300 pig-eye trials, human ops next
Read more...Infinity Bio raises $8m to decode the antibody reactome
Longevity Technology - 24-Jun-2025
Tech screens 1,000s of antibodies per assay; links chronic inflammation to faster ageing
Read more...Cidara’s new flu drug shows strong protection in adults
BioPharma Dive - 23-Jun-2025
It may be a potential one-time seasonal alternative to vaccines without serious side effects
Read more...Parallel Bio raises $21m to replace animal testing with human immune organoids
Longevity Technology - 17-Jun-2025
New platform aims to cut drug discovery by $2B and 9 years using lab-grown human immune models
Read more...Juvena strikes $650m deal with lilly to tackle obesity
Longevity Technology - 11-Jun-2025
AI-driven protein therapies aim to boost muscle health and metabolism alongside weight loss
Read more...Splicebio raises $135m to advance gene therapy for eye disease
FierceBiotech - 11-Jun-2025
SB-007 enters phase 1/2 trials to restore vision in Stargardt disease using novel splicing tech
Read more...University spin-out Astratus unveils breakthrough in antibiotic testing
University of Reading - 10-Jun-2025
New tech delivers same-day results to improve prescriptions and curb rising antimicrobial resistance
Read more...AI-driven leap: Juvenescence expands R&D capabilities with Ro5 acquisition
Longevity Technology - 05-Jun-2025
Ro5’s AI platform boosts Juvenescence’s age-related drug pipeline and fuels UAE healthtech push
Read more...AI-powered biotech Vivodyne aims to end animal testing with $40m funding boost
Longevity Technology - 30-May-2025
Biotech firm uses AI and robotics to test drugs on real human tissues, not animals
Read more...Magnitude Biosciences secures funding to boost AI-powered drug discovery
BusinessLive - 29-May-2025
Biotech firm to create skilled jobs as it scales innovative platform for healthier ageing therapies
Read more...Neuralink raised $600 million, reaching a $9 billion valuation
Longevity Technology - 28-May-2025
The company is still in early stages but attracting strong investor interest
Read more...Maxwell’s AI platform drives revenue growth through health innovation
Live Forever Club - 27-May-2025
India partnerships and FDA progress boost future income
Read more...Boundless bio cuts staff and rethinks strategy after lead drug fails in early trials
FierceBiotech - 27-May-2025
Biotech pivots to drug combo after monotherapy safety and efficacy setbacks
Read more...Starfish neuroscience unveils plans for tiny, wireless brain chip
The Verge - 24-May-2025
Valve CEO’s BCI firm builds battery-free chip to interact with multiple brain regions
Read more...Altos Labs expands longevity portfolio with Dorian Therapeutics acquisition
Longevity Technology - 23-May-2025
Dorian’s anti-senescence tech adds firepower to Altos Labs’ rejuvenation strategy
Read more...Tomorrow.Bio raises 5m to bring cryonics and life-after-death hopes to the U.S.
EU-Startups - 22-May-2025
Berlin startup freezes bodies, hoping for future revival
Read more...UK biotech Juvenescence secures over $150m to develop therapies
Endpoints News - 21-May-2025
Juvenescence expands pipeline and UAE presence with new funding to tackle age-related diseases
Read more...23andMe’s fall from fame ends in Regeneron takeover
BBC - 19-May-2025
Regeneron buys 23andMe for $256M, pledges to protect user data and boost drug discovery
Read more...AI startup Somite raises $47m to revolutionize stem cell therapy
Longevity Technology - 16-May-2025
Somite AI uses DeltaStem to speed up and scale stem cell engineering
Read more...The billionaire blind spot: why longevity science is being overlooked
NFX - 15-May-2025
Unlocking ageing science could add decades of life—but funding is the missing link
Read more...BrightFocus Foundation fuels early research on aging diseases with $13m grants
Longevity Technology - 13-May-2025
Private funding supports global scientists tackling Alzheimer’s, vision loss, and glaucoma
Read more...Rewriting the cell's code: HAYA’s mission to transform genomic medicine
Longevity Technology - 12-May-2025
Biotech startup raises $65M to develop RNA therapies that reprogram disease-driving cell states
Read more...Xprize longevity contest narrows field to 40 semi-finalists
The Guardian - 11-May-2025
Drawn from over 1,000 global contenders, the selected teams are one step closer to the $101M prize
Read more...Hundred health acquires BellSant to supercharge AI longevity platform strapline:
Longevity Technology - 08-May-2025
AI-driven health platform gears up for launch with cutting-edge longevity data
Read more...NewLimit secures $130m to accelerate epigenetic reprogramming for longevity
Longevity Technology - 06-May-2025
The biotech company aims to target the root causes of ageing to develop therapies to extend lifespan
Read more...Lilly bets big on AI-discovered ALS drug in $415m deal
FierceBiotech - 06-May-2025
AI-powered therapy offers new hope for ALS as early trials approach
Read more...Recursion overhauls pipeline after key drug fails in mid-stage trial
Endpoints News - 05-May-2025
With $509M in cash, biotech bets on fewer, stronger programs ahead of 2025 data
Read more...Biotech shake-up: Unity and Mammoth announce major layoffs amid strategic shifts
FierceBiotech - 05-May-2025
Unity exits eye drug race, Mammoth tightens focus on CRISPR pipeline
Read more...Stately Bio emerges with AI-powered window into living cells
Endpoints News - 01-May-2025
AI startup decodes live cell behaviour using simple imaging and machine learning
Read more...A brighter path for Parkinson’s: light therapy device nears FDA finish line
Longevity Technology - 28-Apr-2025
PhotoPharmics secures $6 million to advance its home-based Celeste device
Read more...Catalytic antibodies lose their champion
Fight Aging! - 23-Apr-2025
Covalent Biosciences falters amid investor caution, patent expiry, and steep development costs
Read more...Biolinq secures $100m to launch needle-free glucose monitor
FierceBiotech - 22-Apr-2025
Tracks glucose, activity, and sleep—offering a simpler option for people with Type 2 diabetes
Read more...Breakthrough drug targets liver regeneration with 21.5m boost
Longevity Technology - 17-Apr-2025
HepaRegeniX advances trials for a novel liver regeneration therapy
Read more...AI alliance to redefine the future of ageing and therapeutics
Juvenescence - 16-Apr-2025
M42 and Juvenescence join forces to accelerate precision medicine and longevity
Read more...Science corp secures major funding to restore sight with BCI tech
Longevity Technology - 15-Apr-2025
A next-gen retinal implant offers new hope for vision loss from macular degeneration
Read more...Switching genes, not sequences: the rise of epigenetic editing
Chemistry World - 09-Apr-2025
Precision drugs use chemical tags to control genes without changing DNA
Read more...New drug for Parkinson’s may keep symptoms under control with just weekly injections
Longevity Technology - 09-Apr-2025
It avoids common delivery problems and enters Phase 1 trials in 2025
Read more...China’s RiboX beats rivals to launch first circular RNA clinical trial
Endpoints News - 04-Apr-2025
A stealthy Shanghai startup pioneers a longer-lasting, safer alternative to mRNA and gene therapies
Read more...Isomorphic Labs secures $600m to supercharge AI drug discovery
FierceBiotech - 31-Mar-2025
Backed by Nobel science, the Alphabet spinout speeds up AI drug development
Read more...Tribune Therapeutics secures 37m to tackle fibrosis at its source
Longevity Technology - 28-Mar-2025
Scandinavian biotech targets fibrosis with novel scar-blocking therapies
Read more...23andMe files for bankruptcy after data breach and financial struggles
BBC - 24-Mar-2025
Company is looking for a buyer, raising concerns about the security of customer DNA data
Read more...Bit.bio cuts 25% of staff as it shifts from therapy development to lab research
FierceBiotech - 19-Mar-2025
Company aims to grow its product line and biotech partnerships
Read more...Mito Health raised $4 million to grow its AI-powered health platform
Longevity Technology - 18-Mar-2025
It uses blood tests to find early health risks and gives personalised advice
Read more...AstraZeneca bets $1 billion on revolutionary cancer therapy
The Guardian - 17-Mar-2025
AstraZeneca acquires EsoBiotec to revolutionize cell therapy with faster, more accessible treatments
Read more...Augustine Therapeutics raises $84.8m for safer neuro and metabolic drugs
Longevity Technology - 12-Mar-2025
Clinical trials are beginning, backed by major investors like Novo Holdings
Read more...Hinge Health is filing for an IPO after cutting losses and boosting revenue
Endpoints News - 10-Mar-2025
The IPO could mark a revival in digital health investments
Read more...Scientists plan to reproduce groundbreaking rejuvenation experiment in rats
Live Forever Club - 06-Mar-2025
No donation too small to help extend Katcher's extracellular particles study
Read more...Trimtech secures $31m to tackle neurodegenerative diseases
Longevity Technology - 06-Mar-2025
Targeted protein degradation tackles harmful aggregates while sparing healthy proteins
Read more...Tenaya raises $52.5m to push forward gene therapy trials
Longevity Technology - 05-Mar-2025
The biotech firm accelerates clinical trials for TN-201 and TN-401, targeting genetic heart disease
Read more...Jupiter Neurosciences partners with Aquanova to develop longevity products
GlobeNewswire - 04-Mar-2025
New collaboration aims to bring scientifically-backed solutions for ageing and healthspan
Read more...AbbVie joins the obesity drug race with $2.2b Gubra deal
Endpoints News - 03-Mar-2025
The pharma giant bets on amylin therapy to enter the weight-loss market
Read more...Bio-recell and AcouSort join forces to advance cell isolation
Bio-ReCell - 03-Mar-2025
The partnership merges acoustic tech with Revive™ SVF to boost stem cell purification
Read more...Biograph: the elite longevity startup redefining preventive health
TechCrunch - 28-Feb-2025
Backed by Peter Attia, this startup uses advanced diagnostics to optimize lifespan
Read more...Vertex ends gene editing deal with Verve amid R&D shift
FierceBiotech - 27-Feb-2025
Verve regains full rights to its liver disease program as it moves forward independently
Read more...Bicycle Therapeutics eyes transformational growth in 2025
Business Weekly - 25-Feb-2025
With nearly $880 million in cash, Bicycle Therapeutics advances innovative cancer therapies
Read more...Cyclarity Therapeutics advances series A tranche 2 funding to accelerate breakthrough cardiovascular treatment
Live Forever Club - 20-Feb-2025
Statins only slow down the progression of atherosclerosis – imagine if we could actually cure it!
Read more...Maxwell Biosciences makes progress in infectious disease treatment
Live Forever Club - 19-Feb-2025
Investors are taking interest as the company moves toward human trials
Read more...Bio-ReCell and BIOTEM collaborate to enhance T-cell therapy
Bio-ReCell - 19-Feb-2025
The partnership adds BIOTEM’s antibodies to Bio-ReCell’s kits to boost cell therapy precision and scale
Read more...Subsense unveils non-surgical brain-computer interface with $17m boost
MassDevice - 18-Feb-2025
Nanoparticles power a new era of brain-computer interaction
Read more...Europe’s first 100m consumer health fund targets proactive care revolution
Longevity Technology - 18-Feb-2025
naturalX backs startups reshaping wellness and prevention
Read more...Mair Therapeutics targets Parkinson’s with AI-driven drug discovery
Longevity Technology - 17-Feb-2025
The Dutch startup is using ion channel research and advanced tech to develop new treatments
Read more...VERIGRAFT secures 1.2m to revolutionize 3D-printed arterial grafts
Tech.eu - 14-Feb-2025
A Eurostars-backed project advancing personalized vascular grafts
Read more...Junevity secures $10m to pioneer “cell reset” therapies for longevity
Longevity Technology - 13-Feb-2025
Backed by AI and genetics, Junevity targets age-related diseases
Read more...Five Alarm Bio seeking funding to develop drugs targeting the chronic diseases of ageing
Live Forever Club - 12-Feb-2025
Promising preclinical results suggest a clear path towards drug development
Read more...Nucleus brings whole-genome health testing to the masses
Longevity Technology - 30-Jan-2025
Cutting-edge DNA analysis provides affordable, real-time health insights
Read more...The NAM catalyst award: Inspiring bold ideas for a healthier future in ageing
Live Forever Club - 27-Jan-2025
Winners receive $50,000 and global networking opportunities
Read more...Neko Health secures $260m to revolutionize preventive care
Longevity Technology - 23-Jan-2025
Full-body scans drive early detection as Neko expands globally
Read more...LinkGevity’s drug fights ageing and kidney disease, gains NASA’s support
Business Weekly - 23-Jan-2025
With backing from NASA and the Crick Institute, clinical trials are set to begin
Read more...Arctic Therapeutics secures €26.5M to advance dementia drugs
Longevity Technology - 21-Jan-2025
Early trials show reduced stroke risks and slower progression
Read more...Convergence Medical raises $3.1m for groundbreaking surgical robot
MassDevice - 21-Jan-2025
V01, the first arthroscopic robot, gains FDA breakthrough status and targets global growth
Read more...Brain surgery reimagined: microrobots unlock new frontiers
Independent - 17-Jan-2025
Tiny robots tested in animals promise less invasive neurological treatments
Read more...Roche taps Dyno Therapeutics' AI-driven capsids for neurological gene therapy
Genetic Engineering & Biotechnology News (GEN) - 15-Jan-2025
A partnership advancing synthetic AAV vectors to tackle gene therapy challenges
Read more...AI startup raises $41M to build a universal biology research tool
Longevity Technology - 15-Jan-2025
Company aims to predict diseases, design therapies, and revolutionise research
Read more...Nanomedicines to reduce invasive treatments for inflammatory diseases
Longevity Technology - 14-Jan-2025
It holds potential for treating inflammation, cancer, ageing, and autoimmunity
Read more...Scaling innovation: Daewoong pioneers mass production of organoids
Korea Biomedical Review (KBR) - 13-Jan-2025
A national project aims to revolutionize regenerative medicine with advanced automation
Read more...Tuning the future: epigenetic editing breaks new ground in genetic medicine
Endpoints News - 12-Jan-2025
Tune Therapeutics secures $175M to pioneer precise gene modulation therapies
Read more...Tenvie Therapeutics raises major funding to tackle age-related diseases
Longevity Technology - 10-Jan-2025
Dual-action therapies tackling inflammation, metabolism, and neurodegeneration
Read more...Patients Know Best secures funding to advance digital health records
Digital Health - 07-Jan-2025
Funding supports NHS digitalisation goals and global expansion of personal health record platform
Read more...General Proximity uses biological proximity to develop new medicines
Longevity Technology - 06-Jan-2025
The company has raised $16 million from investors
Read more...Nuritas raised $42M to expand AI-driven peptide discovery for sustainable solutions
Longevity Technology - 23-Dec-2024
Their platform speeds up finding peptides from plants, making healthcare solutions faster
Read more...Revolutionizing healthy ageing: ARPA-H's bold new initiative
Advanced Research Projects Agency for Health (ARPA-H) - 19-Dec-2024
Extending healthspan and tackling age-related challenges with innovative therapies and technologies
Read more...DeepLife secures $10M for AI-driven healthcare innovation using digital twins
Longevity Technology - 17-Dec-2024
This breakthrough combines large biological datasets and advanced AI tools
Read more...Precision Neuroscience raised $102M, closing its Series C funding
MobiHealthNews - 16-Dec-2024
Company competes with Neuralink and Synchron to revolutionise AI-human integration
Read more...Angitia secures $120m to tackle bone health challenges
Longevity Technology - 12-Dec-2024
Biotech firm advances osteoporosis therapies and strengthens leadership with key appointment
Read more...LongGame invests in early-stage biotech startups targeting ageing and life extension
Longevity Technology - 12-Dec-2024
Focus areas include gene editing, stem cell therapies, and affordable health solutions
Read more...Capstan Medical secures $110m to revolutionize heart valve repair with robotic technology
MobiHealthNews - 11-Dec-2024
Innovative robotic solutions aim to improve treatment for millions with heart valve disease
Read more...Pioneering RNA therapies to transform heart disease treatment
King’s College London - 11-Dec-2024
A £50M centre unlocking heart regeneration with RNA therapies
Read more...BioAge halts obesity drug trial after safety concerns
BioPharma Dive - 07-Dec-2024
Liver enzyme spikes in participants prompt a major setback for the biotech firm
Read more...Jupiter Neurosciences raises $11M for a resveratrol-based Parkinson’s treatment
Longevity Technology - 05-Dec-2024
The treatment "JOTROL" shows promise in cognitive and brain health conditions
Read more...Abselion raises 6.6 million to transform protein quantification
BGF - 05-Dec-2024
Investors back Amperia for faster, more accessible protein measurement
Read more...Refoxy raises millions to advance FOXO3 ageing therapies
Longevity Technology - 04-Dec-2024
Pioneering treatments target underlying mechanisms of age-related diseases like pulmonary fibrosis
Read more...Startup secures major funding to revolutionize chronic disease testing
Longevity Technology - 02-Dec-2024
Powered by AI, pocdoc accelerates early detection and treatment of chronic diseases
Read more...Doron Therapeutics secures $11m to advance osteoarthritis drug
Longevity Technology - 29-Nov-2024
Breakthrough MOTYS moves to phase 3 trials, promising lasting relief for knee osteoarthritis
Read more...Oura and Dexcom join forces to transform metabolic health
Longevity Technology - 21-Nov-2024
Integrated glucose monitoring and wearable insights offer a personalized approach to health tracking
Read more...TRexBio raises $84M to develop immune therapies targeting inflammation
Longevity Technology - 20-Nov-2024
Funding strengthens their capacity to address unmet needs in immune-related diseases
Read more...
